As of August 5th, 2022, an outbreak has been declared in CAMH’s Emergency Department, located at 1051 Queen Street West due to staff positive COVID-19 cases. This declaration was made in conjunction with Toronto Public Health, CAMH’s Health, Safety and Wellness (HSW), and Infection Prevention and Control (IPAC). The Emergency Department remains open to new patients. However, please advised that wait times might be longer than usual given staffing issues. CAMH has completed contact tracing for all impacted staff and confirmed that no patients have been exposed.
Canada, the second highest consumer of opioids worldwide, must take a comprehensive approach to curb rampant prescribing of opioids and reduce deaths, argue addiction and mental health experts in an analysis in CMAJ (Canadian Medical Association Journal).
The use of prescription opioids in Canada has increased steadily over the past 20 years, with correspondingly skyrocketing numbers of misuse, disorders and deaths. Although prescription opioid misuse in adult and adolescent populations has subsided somewhat from previous peaks, the demand for prescription opioid-related addiction treatment has increased substantially. Most worrisome, in 2015, an estimated 2,000 Canadians died from opioid overdoses, and many provinces are “on track” for a record number of deaths in 2016.
To curb the use, and related harms, of these potent drugs, the authors propose several interventions, including:
developing and enforcing guidelines for prescribing opioids only in exceptional cases where supported by good evidence
prescribing only limited dosages and for limited duration as supported by evidence
establishing real-time electronic prescription monitoring systems across Canada that physicians and pharmacists must consult before prescribing or dispensing opioids
developing a national surveillance system for opioid-related harm indicators, such as emergency department visits and overdose deaths
creating availability of and access to evidence-based treatment of opioid addiction.
“These measures surely will not solve the fundamental causes of the prescription opioid problem, but will reduce some of its acute and long-term consequences, including extensive morbidity…and overdose deaths,” the authors conclude.
In arelated commentary, Drs. M. Eugenia Socias and Keith Ahamad, researchers at the British Columbia Centre for Excellence in HIV/AIDS in Vancouver, BC, say that “changing prescribing practices may help protect patients in the future. However, we’re in the middle of an opioid overdose epidemic due to untreated addiction. Major barriers exist across Canada to access medications that can save lives, like buprenorphine/naloxone, which can be provided in primary care settings.”
To combat its opioid epidemic, the United States has introduced the National Pain Strategy, national guidelines for safer prescribing, recognition of addiction medicine as an official medical subspecialty and efforts to expand access to overdose treatment.
The commentary authors call for a national strategy in Canada that will address overprescribing of opioids and open the doors to better treatment for addiction, especially through primary care providers.
Centre for Addiction and Mental Health
Fuel discovery. Save lives.
Your donation will fund the groundbreaking mental health research that is helping people on the path to recovery.